Effect of LPS on expression of IL-6, BNBD-5 and TNF-α in BMECs
As shown in Fig 1A-C, the levels of IL-6, BNBD-5 and TNF-α in BMECs incubated with LPS were significantly higher than those in the controls, indicating an inflammatory response. In addition, treating cells with LPS increased intracellular TNF-α release (Fig 1D).
Effect of DNA methyl transferase inhibition on TNF-α expression
Treatment with 5-Aza was used to determine the effect of DNA methylation on LPS-induced TNF-a expression in BMECs. The effects of 5-Aza on the viability of cells are shown in Fig 2A. There was no effect on cell viability between 5-Aza-treated cells and the controls. As shown in Fig 2B, cells pre-treated with different concentrations of 5-Aza (1.0, 2.5 and 5.0 µmol/L) for 24, 48 and 72/ hr significantly upregulated TNF-α expression compared to cells treated with LPS only.
Effect of LPS on expression of DNMT1, DNMT2, DNMT3A and DNMT3B in BMECs
The results in Fig 3 shows that the levels of DNMT1, DNMT2, DNMT3A and DNMT3B in cells incubated with LPS were significantly lower than those in the controls. The degree of reduction in gene expression was related to the duration of LPS treatment, with the lowest expression level observed in cells treated with LPS for 3 hr.
Effect of LPS on methylation level in the TNF-α promoter region in BMECs
As shown in Fig 4A, bisulfite sequencing PCR (BSP) analysis revealed that TNF-α had 12 target CpG sites. As indicated by the results in Fig 4B, significant hypomethylation was observed in LPS-treated cells. DNA methylation significantly decreased in the TNF-α promoter regions by 6.39% (73.33% vs. 66.94%), representing a reduction from 60.00% to 20.00% at the -323 site, 80.00% to 40.00% at the -270 site and 90.00% to 60.00% at the -245 site.
TNF-a is a multifunctional cytokine that exerts a wide range of pro-inflammatory effects. Several studies have found that TNF-α is related to various inflammation pathogenesis
(Mohammadpour et al., 2019). For example, a previous study confirmed that LPS stimulated the expression of TNF-α in BMECs (
Liu M et al., 2019), although the exact molecular mechanisms was not deciphered. Other studies showed that DNA methylation regulated the expression of TNF-α. In human pathology, the mRNA expression of TNF-α and methylation status of its promoter are inversely related (
Wilson, 2008). In rat liver cells, the T-2 toxin-induced increase in the expression of TNF-α was associated with DNA methylation
(Liu et al., 2019). Treatment with 5-Aza augmented the production of TNF-α by inhibiting DNA methylation in macrophages. Moreover, demethylation by 5-Aza reportedly increased the expression of TNF-α, which was induced by LPS stimulation in broiler peripheral blood mononuclear cells
(Shen et al., 2016). Consistent with the above studies, the results of the present study showed that LPS treatment significantly increased TNF-α mRNA expression, but reduced CpG methylation levels at specific sites in the TNF-α promoter. We also observed that demethylation enhanced the effect of LPS on TNF-a expression in BMECs. These results supported other studies showing that DNA methylation inhibited LPS-induced TNF-a expression. However, another study reported that, in mice lung tissues, 5-Aza reduced the LPS-induced TNF-a expression
(Huang et al., 2016). This indicates that the TNF-a expression may be differentially regulated in cells of different origins.
Catalysed by DNMTs, DNA methylation is a type of epigenetic modification related to a variety of inflammation pathogenesis and transcriptional regulation. DMNT1 is mainly involved in maintaining the methylation state, while DNMT3A and DNMT3B are the
de novo methyl transferases
(Mo et al., 2019). We detected the mRNA expression of DNMT1, DNMT2, DNMT3A and DNMT3B and showed that their expression was significantly decreased after LPS treatment. According to recent studies, the expression of DNMT1and DNMT3B decreases in human dental pulp cells after LPS stimulation
(Cai et al., 2020). DNMT1 was also significant decreased after LPS stimulation of broiler peripheral blood mononuclear cells. In addition, LPS decreased DNMT1, DNMT3A and DNMT3B expression as well as total DNMTs activities in human retinal pigment epithelial cells
(Maugeri et al., 2018). However, contradictory results have also been reported: For example, treatment with LPS was shown to increase DNMT1, DNMT3A and DNMT3B in bovine endometrial cells
(Jun et al., 2018). Further, DNMTI was significantly increased in human umbilical vein endothelial cells following LPS treatment
(Ma et al., 2019) and increased DNMT1 expression was observed in LPS-treated THM-1 derived macrophages
(Tang et al., 2019). gain, differences in cell types or LPS treatment may be responsible for these disparities.